Skip to main content
Premium Trial:

Request an Annual Quote

Applied BioCode Licenses Patents to Molecular Devices

NEW YORK (GenomeWeb) – Applied BioCode said today that it has signed a license and supply agreement for its barcoded magnetic bead (BMB) technology with bioanalytics firm Molecular Devices.

The deal gives Molecular Devices access to specific Applied BioCode BMB patents for use on its own microplate reading devices within the life sciences, food and beverage research, and environmental testing markets. Further details of the agreement were not disclosed.

“Our barcoded magnetic bead technology combined with Molecular Devices microplate reading devices will expand its capabilities from single to multiple analyte tests and create a formidable force for multiplexed testing within these markets," Winston Ho, president of Applied BioCode, said in a statement.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.